A private regenerative medicine provider treating patients at two Belgrade premises with mesenchymal stem cell and related cell therapies.
Swiss Medica is a private regenerative medicine group whose website, startstemcells.com, covers several European premises under one brand. The site says the group has been working in regenerative medicine since 2011 and that more than 10,000 patients have been treated across its conditions. That figure is the company's own claim and is not independently verified.
For Belgrade specifically, the site gives two separate addresses: what it calls a stem cell innovation centre and hospital at Slovacka 90, and a stem cell therapy clinic at Ugrinovacki put 16a. Both are given with Belgrade postcodes, which is the clearest evidence on the site that patients are treated at real premises in the city rather than through a referral page.
The treatments described centre on mesenchymal stem cells, a type of adult stem cell. The site also lists exosome and secretome therapy, which uses the material cells release rather than the cells themselves, neural stem cell therapy, and therapies using regulatory T-cells, macrophages and natural killer cells, which are immune cells. Treatment is described as combined with device-based therapies and rehabilitation rather than given alone.
The range of conditions listed is wide and includes several, such as autism and motor neurone disease, for which stem cell therapy is not an established treatment anywhere. Anyone considering treatment should discuss the evidence for their own condition with an independent specialist. The site does not publish prices and asks patients to book a consultation for a quotation.
The site lists the following conditions; several are not conditions for which cell therapy is an established treatment, and the listing here reflects what the site claims rather than any endorsement.
The site says its core treatment is mesenchymal stem cells, supported by exosome and secretome preparations and by several immune cell types.
The site lists its doctors by first name and role rather than by full name and registration details, which limits how far a reader can check their credentials.
The site describes two distinct Belgrade premises, one presented as an innovation centre and hospital on Slovacka and one as a therapy clinic on Ugrinovacki put, together with a further wellness and rehabilitation clinic in Slovenia. It gives a single international telephone number in Switzerland rather than local Serbian numbers, and the pages read do not name a Serbian operating licence or an accrediting body for the Belgrade premises.
The site refers to treatment pricing but does not publish figures; it asks prospective patients to arrange a consultation before a cost is given.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.